1. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant treatment of Colon Cancer (MOSAIC) Investigators. N Engl J Med 350: 2343–2351
2. Aschele C, Friso ML, Pucciarelli S, Lonardi S, Sartor L, Fabris G, Urso DL, Del Bianco P, Sotti G, Lise M, Monfardini S (2005) A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 16: 1140–1146
3. Birbeck KF, Quirke P (1999) Reporting protocols in colorectal cancer. CPD Bull Cell Pathol 1: 58–64
4. Blackstock A, Tepper J, Hess S (2000) Oxaliplatin: in vitro and in vivo evidence of its radiation sensitizing activity. Int J Rad Oncol Biol Phys 46: 92–94
5. Blackstock AW, Tepper JE, Case LD, Anderson J, Hess S (2002) In vitro and in vivo radiosensitization of colon cancer cells by cis-[(1R2R)-1,2-cyclohexanediamine-N,N′] [oxalato(2-)-O,O′]platinum (oxaliplatin). Int J Mol Med 10 (Suppl 1): S68